-
HemaFus BCR-ABL1(P210P190, and P230) Qualitative Detection Kit(PCR-Fluorescent Probing)
Human diseasesReal-time PCR is applied to qualitatively detect three types of BCR-ABL1 fushion gene, i.e, P210 (e13a2 and e14a2),P190(e1a2) and P230 (e19a2) in peripheral blood or bone marrow samples, which allows typing detection of P210, P190 and P230.but cannot distinguish between e13a2 and e14a2 in P210
-
HemaFus BCR-ABL1(P230) Fusion Gene Quantitative Detection Kit (PCR-Fluorescent Probing)
Human diseasesThe BCR-ABL1 P230 (e19a2) fusion gene is quantitatively detected by real-time PCR.
-
HemaFus CBFB-MYH11 Fusion Gene Qualitative Detection Kit (PCR-Fluorescent Probing)
Human diseasesThe CBFB-MYH11 fusion gene is qualitatively detected by real-time PCR.
-
HemaFus CBFB-MYH11 Fusion Gene Quantitative Detection Kit(PCR-Fluorescent Probing)
Human diseasesThe CBFB-MYH11 fusion gene is quantitatively detected by real-time PCR.
-
HemaFus ETV6-RUNX1 FusionGene Qualitative Detection Kit(PCR-Fluorescent Probing)
Human diseasesThe ETV6-RUNX1 fusion gene is qualitatively detected by real-time PCR.
-
HemaFus ETV6-RUNX1 FusionGene Quantitative Detection Kit(PCR-Fluorescent Probing)
Human diseasesThe ETV6-RUNX1 fusion gene is Quantitative detected by real-time PCR.
-
HemaFus Human 58-Fusion Gene Screening Kit(Multiplex RT-PCR)
Human diseasesMultiplex reverse transcription-polymerase chain reaction (RT-PCR) technology is applied to qualitatively detect 177 distinct mRNA fusion gene subtypes within 58 different fusion genes that are associated with ALL, AML, CML, other mixed leukemia,and unspecified leukemias.
-
HemaFus Human 60-Fusion Gene Screening Kit(PCR-Fluorescent Probing)
Human diseasesThe multiplex real-time PCR combined with Taqman probes is applied to qualitatively detect 241 subtypes within 60 different fusion genes that are associated with ALL,AML，CML，othermixed-phenotype leukemia, and leukemia of unspecified cell type.
